Goodwill of Encompass Health Corp from 30 Jun 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Encompass Health Corp quarterly Goodwill in USD history and change rate from 30 Jun 2010 to 31 Dec 2025.
  • Encompass Health Corp Goodwill for the quarter ending 31 Dec 2025 was $1,317,600,000, a 2.6% increase year-over-year.
Source SEC data
View on sec.gov
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Change (%)

Encompass Health Corp Quarterly Goodwill (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $1,317,600,000 +$33,600,000 +2.6% 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 $1,303,000,000 +$19,000,000 +1.5% 30 Sep 2025 10-Q 31 Oct 2025 2025 Q3
Q2 2025 $1,303,000,000 +$19,000,000 +1.5% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $1,284,000,000 +$2,700,000 +0.21% 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 $1,284,000,000 +$2,700,000 +0.21% 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 $1,284,000,000 +$2,700,000 +0.21% 30 Sep 2024 10-Q 01 Nov 2024 2024 Q3
Q2 2024 $1,284,000,000 +$13,300,000 +1% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $1,281,300,000 +$10,600,000 +0.83% 31 Mar 2024 10-Q 02 May 2024 2024 Q1
Q4 2023 $1,281,300,000 +$18,100,000 +1.4% 31 Dec 2023 10-K 26 Feb 2026 2025 FY
Q3 2023 $1,281,300,000 +$33,900,000 +2.7% 30 Sep 2023 10-Q 01 Nov 2023 2023 Q3
Q2 2023 $1,270,700,000 -$1,185,800,000 -48% 30 Jun 2023 10-Q 04 Aug 2023 2023 Q2
Q1 2023 $1,270,700,000 -$1,185,800,000 -48% 31 Mar 2023 10-Q 03 May 2023 2023 Q1
Q4 2022 $1,263,200,000 +$26,200,000 +2.1% 31 Dec 2022 10-K 26 Feb 2026 2025 FY
Q3 2022 $1,247,400,000 -$1,170,200,000 -48% 30 Sep 2022 10-Q 02 Nov 2022 2022 Q3
Q2 2022 $2,456,500,000 +$44,200,000 +1.8% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 $2,456,500,000 +$137,800,000 +5.9% 31 Mar 2022 10-Q 03 May 2022 2022 Q1
Q4 2021 $1,237,000,000 +$8,800,000 +0.72% 31 Dec 2021 10-K 28 Feb 2025 2024 FY
Q3 2021 $2,417,600,000 +$98,900,000 +4.3% 30 Sep 2021 10-Q 02 Nov 2021 2021 Q3
Q2 2021 $2,412,300,000 +$93,600,000 +4% 30 Jun 2021 10-Q 03 Aug 2021 2021 Q2
Q1 2021 $2,318,700,000 +$6,600,000 +0.28% 31 Mar 2021 10-Q 04 May 2021 2021 Q1
Q4 2020 $1,228,200,000 +$9,300,000 +0.76% 31 Dec 2020 10-K 28 Feb 2024 2023 FY
Q3 2020 $2,318,700,000 +$13,500,000 +0.59% 30 Sep 2020 10-Q 02 Nov 2020 2020 Q3
Q2 2020 $2,318,700,000 +$207,100,000 +9.8% 30 Jun 2020 10-Q 31 Jul 2020 2020 Q2
Q1 2020 $2,312,100,000 +$200,500,000 +9.5% 31 Mar 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 $1,218,900,000 -$881,900,000 -42% 31 Dec 2019 10-K 27 Feb 2023 2022 FY
Q3 2019 $2,305,200,000 +$224,100,000 +11% 30 Sep 2019 10-Q 31 Oct 2019 2019 Q3
Q2 2019 $2,111,600,000 +$36,900,000 +1.8% 30 Jun 2019 10-Q 31 Jul 2019 2019 Q2
Q1 2019 $2,111,600,000 +$138,500,000 +7% 31 Mar 2019 10-Q 01 May 2019 2019 Q1
Q4 2018 $2,100,800,000 +$128,200,000 +6.5% 31 Dec 2018 10-K 25 Feb 2022 2021 FY
Q3 2018 $2,081,100,000 +$109,400,000 +5.5% 30 Sep 2018 10-Q 31 Oct 2018 2018 Q3
Q2 2018 $2,074,700,000 +$125,100,000 +6.4% 30 Jun 2018 10-Q 02 Aug 2018 2018 Q2
Q1 2018 $1,973,100,000 +$41,700,000 +2.2% 31 Mar 2018 10-Q 02 May 2018 2018 Q1
Q4 2017 $1,972,600,000 +$45,400,000 +2.4% 31 Dec 2017 10-K 26 Feb 2021 2020 FY
Q3 2017 $1,971,700,000 +$56,100,000 +2.9% 30 Sep 2017 10-Q 31 Oct 2017 2017 Q3
Q2 2017 $1,949,600,000 +$49,900,000 +2.6% 30 Jun 2017 10-Q 02 Aug 2017 2017 Q2
Q1 2017 $1,931,400,000 +$39,500,000 +2.1% 31 Mar 2017 10-Q 28 Apr 2017 2017 Q1
Q4 2016 $1,927,200,000 +$37,100,000 +2% 31 Dec 2016 10-K 27 Feb 2020 2019 FY
Q3 2016 $1,915,600,000 +$810,600,000 +73% 30 Sep 2016 10-Q 28 Oct 2016 2016 Q3
Q2 2016 $1,899,700,000 +$802,200,000 +73% 30 Jun 2016 10-Q 29 Jul 2016 2015 Q2
Q1 2016 $1,891,900,000 +$801,900,000 +74% 31 Mar 2016 10-Q 28 Apr 2016 2015 Q1
Q4 2015 $1,890,100,000 +$806,100,000 +74% 31 Dec 2015 10-K 27 Feb 2019 2018 FY
Q3 2015 $1,105,000,000 +$613,300,000 +125% 30 Sep 2015 10-Q 29 Oct 2015 2015 Q3
Q2 2015 $1,097,500,000 +$605,800,000 +123% 30 Jun 2015 10-Q 30 Jul 2015 2015 Q2
Q1 2015 $1,090,000,000 +$633,100,000 +139% 31 Mar 2015 10-Q 01 May 2015 2015 Q1
Q4 2014 $1,084,000,000 +$627,100,000 +137% 31 Dec 2014 10-K 28 Feb 2018 2017 FY
Q3 2014 $491,700,000 +$34,500,000 +7.5% 30 Sep 2014 10-Q 28 Oct 2014 2014 Q3
Q2 2014 $491,700,000 +$34,500,000 +7.5% 30 Jun 2014 10-Q 29 Jul 2014 2014 Q2
Q1 2014 $456,900,000 +$13,500,000 +3% 31 Mar 2014 10-Q 29 Apr 2014 2014 Q1
Q4 2013 $456,900,000 +$19,600,000 +4.5% 31 Dec 2013 8-K 19 Sep 2017 2016 FY
Q3 2013 $457,200,000 +$19,900,000 +4.6% 30 Sep 2013 10-Q 29 Oct 2013 2013 Q3
Q2 2013 $457,200,000 +$35,500,000 +8.4% 30 Jun 2013 10-Q 30 Jul 2013 2013 Q2
Q1 2013 $443,400,000 +$21,700,000 +5.1% 31 Mar 2013 10-Q 26 Apr 2013 2013 Q1
Q4 2012 $437,300,000 +$15,600,000 +3.7% 31 Dec 2012 10-K 25 Feb 2016 2015 FY
Q3 2012 $437,300,000 +$17,000,000 +4% 30 Sep 2012 10-Q 26 Oct 2012 2012 Q3
Q2 2012 $421,700,000 +$1,400,000 +0.33% 30 Jun 2012 10-Q 27 Jul 2012 2012 Q2
Q1 2012 $421,700,000 -$9,600,000 -2.2% 31 Mar 2012 10-Q 01 May 2012 2012 Q1
Q4 2011 $421,700,000 +$1,400,000 +0.33% 31 Dec 2011 10-K 02 Mar 2015 2014 FY
Q3 2011 $420,300,000 -$8,600,000 -2% 30 Sep 2011 10-Q 04 Nov 2011 2011 Q3
Q2 2011 $420,300,000 -$3,400,000 -0.8% 30 Jun 2011 10-Q 04 Aug 2011 2011 Q2
Q1 2011 $431,300,000 31 Mar 2011 10-Q 02 May 2011 2011 Q1
Q4 2010 $420,300,000 31 Dec 2010 10-K 20 Feb 2014 2013 FY
Q3 2010 $428,900,000 30 Sep 2010 10-Q 03 Nov 2010 2010 Q3
Q2 2010 $423,700,000 30 Jun 2010 10-Q 05 Aug 2010 2010 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.